Isthmus Partners’s Varian Medical Systems, Inc. VAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-588
Closed -$66K 280
2018
Q3
$66K Sell
588
-175
-23% -$19.8K 0.02% 163
2018
Q2
$87K Sell
763
-59,929
-99% -$7.17M 0.02% 155
2018
Q1
$7.44M Sell
60,692
-1,651
-3% -$197K 2.01% 13
2017
Q4
$6.93M Sell
62,343
-496
-0.8% -$53.3K 1.89% 24
2017
Q3
$6.29M Sell
62,839
-1,018
-2% -$104K 1.77% 29
2017
Q2
$6.59M Sell
63,857
-1,319
-2% -$127K 1.93% 17
2017
Q1
$5.94M Sell
65,176
-8,535
-12% -$712K 1.74% 28
2016
Q4
$5.8M Buy
73,711
+138
+0.2% +$11.2K 1.75% 28
2016
Q3
$6.27M Sell
73,573
-1,655
-2% -$135K 1.99% 16
2016
Q2
$5.42M Sell
75,228
-729
-1% -$52.9K 1.78% 31
2016
Q1
$5.33M Buy
75,957
+1,497
+2% +$102K 1.78% 30
2015
Q4
$5.28M Buy
74,460
+405
+0.5% +$28K 1.84% 23
2015
Q3
$4.79M Buy
74,055
+618
+0.8% +$45.1K 1.76% 27
2015
Q2
$5.43M Buy
73,437
+560
+0.8% +$43.8K 1.79% 26
2015
Q1
$6.01M Buy
72,877
+1,332
+2% +$107K 2.04% 19
2014
Q4
$5.43M Buy
+71,545
New +$5.32M 1.85% 25

Other funds holding VAR

Isthmus Partners's VAR Position: Q4 2018 in Review

Isthmus Partners sold out of Varian Medical Systems, Inc. (VAR) in Q4 2018, closing a stake of 588 shares — an estimated $66K sold.

Isthmus Partners first reported a position in VAR in Q4 2014 and held it in 16 quarters. The position peaked at $7.44M in Q1 2018. 607 funds tracked by Wall St. Rank hold VAR as of Q4 2018.

  • Isthmus Partners reported no remaining Varian Medical Systems, Inc. position as of Q4 2018 after selling out during the quarter.
  • Isthmus Partners sold 588 Varian Medical Systems, Inc. shares in Q4 2018, an estimated $66K.
  • Isthmus Partners first reported a position in Varian Medical Systems, Inc. in Q4 2014 and held it in 16 quarters.
  • Isthmus Partners's Varian Medical Systems, Inc. position peaked at $7.44M in Q1 2018.
  • 607 funds tracked by Wall St. Rank held Varian Medical Systems, Inc. as of Q4 2018.

Based on Isthmus Partners's 13F filing for Q4 2018, filed 4 Feb 2019.